Agilent Technologies, Inc. $A Shares Sold by KBC Group NV

KBC Group NV trimmed its stake in Agilent Technologies, Inc. (NYSE:A) by 15.7% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 69,164 shares of the medical research company’s stock after selling 12,892 shares during the period. KBC Group NV’s holdings in Agilent Technologies were worth $7,883,000 as of its most recent filing with the SEC.

Several other large investors have also recently made changes to their positions in A. Mitsubishi UFJ Asset Management Co. Ltd. raised its holdings in shares of Agilent Technologies by 4.3% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 599,581 shares of the medical research company’s stock valued at $82,712,000 after buying an additional 24,687 shares during the period. Massachusetts Financial Services Co. MA boosted its holdings in Agilent Technologies by 13.8% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 14,147,601 shares of the medical research company’s stock valued at $1,925,064,000 after acquiring an additional 1,713,216 shares during the period. CCLA Investment Management boosted its holdings in Agilent Technologies by 1.9% during the 4th quarter. CCLA Investment Management now owns 1,047,488 shares of the medical research company’s stock valued at $142,542,000 after acquiring an additional 19,518 shares during the period. Mirae Asset Global Investments Co. Ltd. grew its position in Agilent Technologies by 20.9% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 53,422 shares of the medical research company’s stock valued at $7,269,000 after acquiring an additional 9,236 shares in the last quarter. Finally, Crossmark Global Holdings Inc. grew its position in Agilent Technologies by 39.6% in the 4th quarter. Crossmark Global Holdings Inc. now owns 33,918 shares of the medical research company’s stock valued at $4,615,000 after acquiring an additional 9,615 shares in the last quarter.

Agilent Technologies Stock Up 0.5%

A stock opened at $133.49 on Thursday. The stock has a market cap of $37.70 billion, a P/E ratio of 26.81, a PEG ratio of 2.36 and a beta of 1.25. The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43. Agilent Technologies, Inc. has a twelve month low of $108.35 and a twelve month high of $160.27. The company’s 50 day moving average is $128.68 and its two-hundred day moving average is $125.45.

Agilent Technologies (NYSE:A) last issued its earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.41 by $0.08. The business had revenue of $1.83 billion during the quarter, compared to analysts’ expectations of $1.80 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The company’s revenue for the quarter was up 10.0% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Research analysts expect that Agilent Technologies, Inc. will post 6.01 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th were paid a $0.255 dividend. This represents a $1.02 annualized dividend and a yield of 0.8%. The ex-dividend date was Tuesday, June 30th. Agilent Technologies’s dividend payout ratio is currently 20.48%.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on the stock. Wall Street Zen raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Saturday, May 30th. Robert W. Baird lifted their price objective on shares of Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a report on Tuesday, May 26th. Weiss Ratings raised shares of Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, June 2nd. HSBC reduced their target price on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a report on Wednesday, June 3rd. Finally, Sanford C. Bernstein assumed coverage on shares of Agilent Technologies in a research report on Friday, June 26th. They issued an “outperform” rating and a $155.00 price target for the company. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $159.35.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.